Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies

By S. Boden, James Kang, H. Sandhu, J. Heller. Spine, 2002

675 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/75f1985f553661b495f409901a0b554bfccaa85c

Citations in the corpus

• A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2 (2016, neutral): “A reassessment of the pilot study of Boden et al. found wound complication rates to be 10% in the BMP-2 group, significantly higher than the control group without BMP-2 use in PLF. 78 Likewise, Chan et al. found significantly higher wound complication rates among the rhBMP-2 treatment group (31”